Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis

Autor: Levis B, Sun Y, He C, Wu Y, Krishnan A, Bhandari PM, Neupane D, Imran M, Brehaut E, Negeri Z, Fischer FH, Benedetti A, Thombs BD, Depression Screening Data (DEPRESSD) PHQ Collaboration, Che L, Levis A, Riehm K, Saadat N, Azar M, Rice D, Boruff J, Kloda L, Cuijpers P, Gilbody S, Ioannidis J, McMillan D, Patten S, Shrier I, Ziegelstein R, Moore A, Akena D, Amtmann D, Arroll B, Ayalon L, Baradaran H, Beraldi A, Bernstein C, Bhana A, Bombardier C, Buji RI, Butterworth P, Carter G, Chagas M, Chan J, Chan LF, Chibanda D, Cholera R, Clover K, Conway A, Conwell Y, Daray F, de Man-van Ginkel J, Delgadillo J, Diez-Quevedo C, Fann J, Field S, Fisher J, Fung D, Garman E, Gelaye B, Gholizadeh L, Gibson L, Goodyear-Smith F, Green E, Greeno C, Hall B, Hampel P, Hantsoo L, Haroz E, Harter M, Hegerl U, Hides L, Hobfoll S, Honikman S, Hudson M, Hyphantis T, Inagaki M, Ismail K, Jeon HJ, Jetté N, Khamseh M, Kiely K, Kohler S, Kohrt B, Kwan Y, Lamers F, Asunción Lara M, Levin-Aspenson H, Lino V, Liu S-I, Lotrakul M, Loureiro S, Löwe B, Luitel N, Lund C, Marrie RA, Marsh L, Marx B, McGuire A, Mohd Sidik S, Munhoz T, Muramatsu K, Nakku J, Navarrete L, Osório F, Patel V, Pence B, Persoons P, Petersen I, Picardi A, Pugh S, Quinn T, Rancans E, Rathod S, Reuter K, Roch S, Rooney A, Rowe H, Santos I, Schram M, Shaaban J, Shinn E, Sidebottom A, Simning A, Spangenberg L, Stafford L, Sung S, Suzuki K, Swartz R, Tan PLL, Taylor-Rowan M, Tran T, Turner A, van der Feltz-Cornelis C, van Heyningen T, van Weert H, Wagner L, Li Wang J, White J, Winkley K, Wynter K, Yamada M, Zhi Zeng Q, Zhang Y

Importance:The Patient Health Questionnaire depression module (PHQ-9) is a 9-item self-administered instrument used for detecting depression and assessing severity of depression. The Patient Health Questionnaire-2 (PHQ-2) consists of the first 2 item

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::6558628498ef31ae1fc2d622654d39d0
https://hdl.handle.net/10453/141897

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability

Autor: LaRocca, NG, Hudson, LD, Rudick, R, Amtmann, D, Balcer, L, Benedict, R, Bermel, R, Chang, I, Chiaravalloti, ND, Chin, P, Cohen, JA, Cutter, GR, Davis, MD, DeLuca, J, Feys, P, Francis, G, Goldman, MD, Hartley, E, Kapoor, R, Lublin, F, Lundstrom, G, Matthews, PM, Mayo, N, Meibach, R, Miller, DM, Motl, RW, Mowry, EM, Naismith, R, Neville, J, Panagoulias, J, Panzara, M, Phillips, G, Robbins, A, Sidovar, MF, Smith, KE, Sperling, B, Uitdehaag, BM, Weaver, J, Multiple Sclerosis Outcome Assessments Consortium (MSOAC)

Publikováno v: Multiple Sclerosis Journal, 24(11), 1469-1484. SAGE Publications Ltd
Multiple Sclerosis (Houndmills, Basingstoke, England)
Multiple Sclerosis Outcome Assessments Consortium (MSOAC) 2018, ' The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability ', Multiple Sclerosis Journal, vol. 24, no. 11, pp. 1469-1484 . https://doi.org/10.1177/1352458517723718

Background: The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) was formed by the National MS Society to develop improved measures of multiple sclerosis (MS)-related disability. Objectives: (1) To assess the current literature and available

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0a745dfe2c0510c571629e202d3b03
https://research.vumc.nl/en/publications/fb260b55-8245-4745-81e8-76c5dc4e2019